4th Antibodies, Antibiotics and Bio Therapeutics Congress & B2B

Bio therapeutics : Early Analytical Development

New biotherapeutics formats are flooding the discovery and development pipelines and with this comes an increasing need for better and faster characterization tools and strategies, and improved biomolecular and biophysical assays for the new biotherapeutics.

Early Analytical Development for Biotherapeutics will present best practice case studies of how industry companies have approached the most important analytical studies occurring during this stage, focusing on the development and optimization of key assays, the application of automation and the challenges of analytical development for novel modalities.

• Assay development
• High throughput analytical development
• Early stage bioassay development
• Analytical development for novel biotherapeutics